A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients-Reference-Cited by-同舟云学术

A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients

Published:2022-12-26 Issue:1 Volume:22 Page:104-117
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Dakin Andrew¹,Borrow Ray²,Arkwright Peter D.¹³

Affiliation:

1. Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK

2. Vaccine Evaluation Unit, UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK

3. Department of Paediatric Allergy & Immunology, Royal Manchester Children’s Hospital, Manchester, UK

Funder

not funding

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2161519

Reference66 articles.

1. Combination vaccines

2. New perspectives for hexavalent vaccines

3. Physician and Parent Opinions

4. European Medicines Agency. Public statement on hexavac: withdrawal of marketing authorisation in the European Union. 2012 [cited 2022 Dec 23]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/hexavac

5. Hexavalent vaccines: increasing options for policy-makers and providers. A review of the data supporting interchangeability (substitution with vaccines containing fewer antigens) and mixed schedules from the same manufacturer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Displaying alphavirus physicochemical consensus antigens on immunogenic liposomes enhances antibody elicitation in mice;Virology;2024-09

2. Vaccination and vaccine-preventable diseases in Africa;Scientific African;2024-06

3. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016);Human Vaccines & Immunotherapeutics;2024-02-08

4. Observational analysis of the immunogenicity and safety of various types of spinal muscular atrophy vaccines;Inflammopharmacology;2024-02-03

5. Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations;Clinical Microbiology Reviews;2023-09-21